Thursday, October 17, 2024

High Growth Tech Stocks in Canada Featuring Kinaxis and Two Others

Must read

The Canadian market has been riding a wave of optimism, with the TSX reaching all-time highs last week, buoyed by the U.S. Fed’s recent rate cut and ongoing enthusiasm for AI technologies. In this favorable environment, high-growth tech stocks like Kinaxis and two others stand out as potential beneficiaries of accelerating corporate earnings and broadening market leadership.

Top 10 High Growth Tech Companies In Canada

Name Revenue Growth Earnings Growth Growth Rating
Docebo 14.71% 33.96% ★★★★★☆
Constellation Software 16.17% 23.55% ★★★★★☆
HIVE Digital Technologies 48.71% 94.27% ★★★★★☆
GameSquare Holdings 38.08% 86.64% ★★★★★☆
Blackline Safety 22.29% 121.23% ★★★★★☆
Medicenna Therapeutics 62.37% 57.20% ★★★★★☆
Sabio Holdings 12.97% 122.50% ★★★★☆☆
BlackBerry 24.19% 79.50% ★★★★★☆
Alpha Cognition 62.98% 69.54% ★★★★★☆
Sernova 76.56% 74.04% ★★★★★☆

Click here to see the full list of 24 stocks from our TSX High Growth Tech and AI Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Kinaxis Inc. offers cloud-based subscription software for supply chain operations across the United States, Europe, Asia, and Canada with a market cap of CA$4.53 billion.

Operations: Kinaxis Inc. generates revenue primarily from its cloud-based subscription software, amounting to $457.72 million. The company operates in various regions including the United States, Europe, Asia, and Canada.

Kinaxis, a leader in supply chain management software, is poised for substantial growth with a 14.5% annual revenue increase forecast, outpacing the Canadian market average of 7%. The company’s strategic client acquisitions, including Mahindra & Mahindra Ltd., enhance its robust portfolio in the complex mobility sector. Despite recent pressures from activist investors like Irenic Capital urging a sale to maximize shareholder value, Kinaxis remains focused on executing its strategic plans. This approach is underpinned by significant R&D investment aimed at advancing its AI capabilities and maintaining competitive advantage in the $16 billion market it serves.

TSX:KXS Earnings and Revenue Growth as at Oct 2024

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Stingray Group Inc. is a global music, media, and technology company with a market cap of CA$498.87 million.

Operations: Stingray Group Inc. generates revenue primarily from two segments: Radio (CA$154.41 million) and Broadcasting and Commercial Music (CA$201.10 million).

Stingray Group, amidst a challenging landscape, is making strides with its innovative Stingray Karaoke app on VIZIO Smart TVs and in Ford’s electric vehicles, enhancing its digital media presence. Despite a modest revenue growth forecast of 4.9% annually—below the Canadian tech sector average—the company is poised for profitability with expected earnings growth of 69.2% per year. This turnaround is supported by strategic share repurchases, signaling confidence in future performance; recently, Stingray committed to buying back up to 3.54 million shares, representing 6.39% of issued capital. These moves reflect a robust strategy to leverage unique entertainment solutions across diverse platforms and geographies while navigating financial complexities marked by significant insider selling and high debt levels.

TSX:RAY.A Revenue and Expenses Breakdown as at Oct 2024
TSX:RAY.A Revenue and Expenses Breakdown as at Oct 2024

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Vitalhub Corp., along with its subsidiaries, offers technology solutions for health and human service providers across Canada, the United States, the United Kingdom, Australia, Western Asia, and other international markets with a market cap of CA$448.70 million.

Operations: The company generates revenue primarily from its healthcare software segment, which reported CA$58.32 million. The business focuses on providing technology solutions to health and human service providers across multiple international markets.

Vitalhub, recently added to the S&P Global BMI Index, exhibits robust growth prospects with its earnings expected to surge by 65.9% annually. This performance starkly contrasts the Canadian market’s average of 14.9%, underscoring its rapid advancement within the tech sector. Moreover, Vitalhub reported a significant revenue increase to CAD 31.49 million in the first half of 2024, up from CAD 25.68 million in the previous year, marking a growth rate of 13.5%. Despite facing challenges like a net loss this quarter due to one-off costs totaling CA$3.1M, these figures highlight Vitalhub’s potential for expansion and innovation in healthcare technology solutions—a sector increasingly reliant on digital transformation.

TSX:VHI Earnings and Revenue Growth as at Oct 2024
TSX:VHI Earnings and Revenue Growth as at Oct 2024

Key Takeaways

Seeking Other Investments?

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.
It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we’re here to simplify it.

Discover if Kinaxis might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Latest article